Jim Simons Acasti Pharma Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.43 - $0.57 $9,962 - $13,205
-23,168 Reduced 25.52%
67,600 $35,000
Q1 2023

May 12, 2023
BUY
$0.43 - $0.81 $39,030 - $73,522
90,768 New
90,768 $42,000
Q1 2022

May 13, 2022
SELL
$0.94 - $1.43 $65,590 - $99,781
-69,777 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$1.07 - $2.01 $28,214 - $53,001
26,369 Added 60.75%
69,777 $88,000
Q3 2021

Nov 12, 2021
BUY
$1.96 - $4.72 $85,079 - $204,885
43,408 New
43,408 $87,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $146M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email